Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	61.58	9.24	20.99	55.89	63.83
Short-Term Investments	165.34	-	22.76	-	-
Cash & Short-Term Investments	226.92	9.24	43.76	55.89	63.83
Cash Growth	2356.33%	-78.89%	-21.71%	-12.44%	2568.39%
Accounts Receivable	0.12	1.17	1.36	1.61	2.01
Other Receivables	1.37	0.01	0	0.02	0.03
Receivables	1.48	1.18	7.47	1.63	2.05
Inventory	-	-	-	1.4	0.98
Prepaid Expenses	2.68	1.08	0.44	0.39	0.42
Other Current Assets	0.08	5.35	1.54	0.03	0.03
Total Current Assets	231.16	16.84	53.22	59.33	67.3
Property, Plant & Equipment	59.54	6.32	0.37	2.49	2.73
Long-Term Investments	0.13	0.13	0.15	-	-
Goodwill	-	24.06	-	-	-
Other Intangible Assets	50.01	50.35	0.03	0.11	0.13
Other Long-Term Assets	0.27	0.18	4.33	2.52	0.26
Total Assets	341.1	97.89	58.09	64.44	70.42
Accounts Payable	9.84	6.41	1.54	0.97	0.73
Accrued Expenses	5.48	3.59	1.3	1.03	0.82
Current Portion of Long-Term Debt	0.05	0.05	-	-	-
Current Portion of Leases	0.96	0.05	-	0.27	0.25
Current Unearned Revenue	1.4	-	-	-	-
Other Current Liabilities	0.5	5.57	0.28	-	-
Total Current Liabilities	18.23	15.66	3.12	2.27	1.8
Long-Term Debt	1.63	1.68	-	-	-
Long-Term Leases	1.43	0.78	-	0.26	0.52
Long-Term Unearned Revenue	26.6	-	-	-	-
Long-Term Deferred Tax Liabilities	2.5	4.59	-	-	-
Other Long-Term Liabilities	0.06	-	0.33	0.64	0.69
Total Liabilities	50.43	22.71	3.45	3.16	3.01
Common Stock	0.07	0.03	0.14	0.14	0.14
Additional Paid-In Capital	522.37	227.59	160.43	159.73	158.59
Retained Earnings	-231.72	-152.44	-105.93	-98.6	-91.33
Comprehensive Income & Other	-0.05	-	-	-	-
Total Common Equity	290.67	75.18	54.64	61.28	67.41
Shareholders' Equity	290.67	75.18	54.64	61.28	67.41
Total Liabilities & Equity	341.1	97.89	58.09	64.44	70.42
Total Debt	4.06	2.55	-	0.52	0.78
Net Cash (Debt)	222.85	6.69	43.76	55.37	63.05
Net Cash Growth	3232.64%	-84.72%	-20.97%	-12.19%	4445.93%
Net Cash Per Share	3.46	0.25	3.08	3.90	6.07
Filing Date Shares Outstanding	74.05	58.69	28	14.21	14.19
Total Common Shares Outstanding	70.67	28.18	14.21	14.2	14.19
Working Capital	212.93	1.17	50.1	57.06	65.5
Book Value Per Share	4.11	2.67	3.84	4.31	4.75
Tangible Book Value	240.66	0.76	54.62	61.17	67.28
Tangible Book Value Per Share	3.41	0.03	3.84	4.31	4.74
Land	0.92	1.28	0.37	0.37	0.37
Buildings	1.77	1.77	-	-	-
Machinery	11.42	2.68	0.02	4.44	4.2
Leasehold Improvements	3.57	0.18	-	4.14	4.14

Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q